Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for the determination of genotoxic impurities in rivaroxaban by high performance liquid chromatography

A technology of high-performance liquid chromatography and rivaroxaban, which is applied in the field of high-performance liquid chromatography for the determination of genotoxic impurities in rivaroxaban, can solve the problems of complex detection methods, inability to effectively detect genotoxic impurities at the same time, and high cost. Achieve the effect of improving detection sensitivity, increasing concentration and injection volume, and good control

Active Publication Date: 2021-10-29
BEIJING YUEKANGKECHUANG PHARM TECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no definite genotoxicity detection method for rivaroxaban. At the same time, the existing detection methods cannot effectively detect multiple specific genotoxic impurities at the same time, and there are technical defects such as complex detection methods (LC-MS) and high cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for the determination of genotoxic impurities in rivaroxaban by high performance liquid chromatography
  • A method for the determination of genotoxic impurities in rivaroxaban by high performance liquid chromatography
  • A method for the determination of genotoxic impurities in rivaroxaban by high performance liquid chromatography

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0022] Experimental example 1 System suitability test:

[0023] Preparation of each impurity localization solution: Take an appropriate amount of 1-hydroxybenzotriazole, SM2, SM3 and 4,5-dichloro-thiophene-2-carboxylic acid reference substance, add water to dissolve and dilute to prepare each 1mL containing the above A solution of 0.1 mg of impurities is used as an impurity localization solution.

[0024] Preparation of rivaroxaban positioning solution: Weigh an appropriate amount of rivaroxaban, add acetonitrile-water (3:2) to dissolve and dilute to make a solution containing 0.1 mg per 1 mL, as the rivaroxaban positioning solution.

[0025] Preparation of the test solution: Take about 10 mg of rivaroxaban, weigh it accurately, put it in a 10ml measuring bottle, add an appropriate amount of water, sonicate for 10 minutes, dilute with water to the mark, shake well, filter, and take the subsequent filtrate as the test solution .

[0026] Reference substance solution: Accurate...

experiment example 2

[0054] Experimental example 2 linearity and range test

[0055] Preparation of impurity (0.1mg / ml) solution: take the appropriate amount of each impurity (1-hydroxybenzotriazole, SM2, SM3, 4,5-dichloro-thiophene-2-carboxylic acid) under the methodology research item, and prepare respectively into a 0.1mg / ml solution, shake well, and set aside.

[0056] Preparation of linear (5μg / ml) solution: Accurately measure 5ml of each of the above impurity (0.1mg / ml) solutions, put them in the same 100ml measuring bottle, add water to dilute to the mark, and shake well to obtain.

[0057] Preparation of 200% linear solution: Accurately measure 3ml of linear (5μg / ml) solution, put it in a 50ml measuring bottle, add water to dilute to the mark, shake well, and you get it.

[0058] Preparation of 120% linear solution: accurately measure 6ml of 200% linear solution, put it in a 10ml measuring bottle, add water to dilute to the mark, shake well, and you get it.

[0059] Preparation of 100% l...

experiment example 3

[0066] Experimental Example 3 Recovery Test

[0067] Preparation of reference substance stock solution: measure 1-hydroxybenzotriazole (0.1mg / ml) solution, SM2 (0.1mg / ml) solution, SM3 (0.1mg / ml) solution, 4,5-dichloro-thiophene - 1ml each of 2-formic acid solution (0.1mg / ml), put in a 100ml measuring bottle, add water to dilute to the mark, shake well, and obtain.

[0068] Preparation of the reference substance solution: Accurately measure 1.5ml of the reference substance stock solution, put it in a 10ml measuring bottle, add water to dilute to the mark, shake well, and obtain.

[0069] 80%, 100%, 120% reference substance solution: Accurately measure 6ml, 7.5ml, 9ml of the reference substance stock solution respectively, place them in three 50ml measuring bottles, add water to dilute to the mark, shake well, and use as 80%, 100% respectively %, 120% reference substance solution.

[0070] Preparation of the test solution: Weigh about 10 mg of rivaroxaban, weigh 9 parts in pa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
particle sizeaaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a method for determining genotoxic impurities in rivaroxaban by high-performance liquid chromatography. The chromatographic column uses octadecylsilane bonded silica gel as a filler; the mobile phase adopts a volume ratio of 69-71:29 ‑31 water and acetonitrile, adjust the pH value of the water to 2.5±0.1; the detection wavelength is 245nm~255nm and / or 225nm~235nm. The high-performance liquid chromatography method for determining genotoxic impurities in rivaroxaban provided by the invention can better control the quality of rivaroxaban.

Description

technical field [0001] The invention relates to the technical field of substance detection, in particular to a method for determining genotoxic impurities in rivaroxaban by high performance liquid chromatography. Background technique [0002] Rivaroxaban is a highly selective, oral agent that directly inhibits factor Xa. Inhibition of factor Xa can interrupt the intrinsic and extrinsic pathways of the blood coagulation cascade, inhibit the generation of thrombin and thrombus formation. Rivaroxaban does not inhibit thrombin (activated factor II), nor has it been shown to have an effect on platelets. Rivaroxaban was jointly developed by Bayer AG of Germany and Johnson & Johnson of the United States. It was first launched in Canada in September 2008, in Europe in the same year, and in the United States in July 2011. [0003] At present, there is no definite genotoxicity detection method for rivaroxaban. At the same time, the existing detection methods cannot effectively detec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06G01N2030/047
Inventor 宋更申李军立安百锋赵红张婷婷
Owner BEIJING YUEKANGKECHUANG PHARM TECH CO LTD